trending Market Intelligence /marketintelligence/en/news-insights/trending/FNjV_G_RQIri5Eag1EOsbQ2 content esgSubNav
In This List

XTL Biopharmaceuticals CFO to step down

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


XTL Biopharmaceuticals CFO to step down

David Kestenbaum plans to cease his services as CFO of XTL Biopharmaceuticals Ltd. and pursue other opportunities.

Kestenbaum will continue working during his notice period, and his successor will be announced in due course.